Table 5.

ANA profile positivity among Sudanese adults with lupus nephritis

ANA profile	SLE Patients		P value
	with lupus nephritis (N=41)	without renal involvement (N=21)
Anti RNP/Sm antibodies	8 (19.5%)	3 (14.3%)	0.61
Anti Sm antibodies	7 (17.1%)	5 (23.8%)	0.52
Anti SS-A antibodies	10 (24.4%)	10 (47.6%)	0.06
Anti RO52 antibodies	16 (39%)	10 (47.6%)	0.51
Anti SS-B antibodies	3 (7.3%)	4 (19%)	0.16
Anti PM-Scl antibodies	1 (2.4%)	0 (0%)	0.47
Anti JO1 antibodies	0 (0%)	3 (14.3%)	0.01*
Anti Centromere B antibodies	0 (0%)	1 (4.8%)	0.16
Anti PCNA antibodies	2 (4.9%)	5 (23.8%)	0.02*
Anti dsDNA antibodies	22 (53.7%)	8 (38.1%)	0.25
Anti Nucleosomes antibodies	11 (26.8%)	3 (14.3%)	0.26
Anti Histones antibodies	7 (17.1%)	3 (14.3%)	0.78
Anti † RP-protein antibodies	2 (4.9%)	2 (9.5%)	0.48
Anti AMA-M2 antibodies	1 (2.4%)	2 (9.5%)	0.22

^†Ribosomal-P-Protein